From: UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
UTRN (low vs. high) | 0.62 | 0.47–0.81 | < 0.001 | 0.51 | 0.34–0.78 | 0.002 |
T (T1T2 vs. T3T4) | 2.00 | 1.44–2.77 | < 0.001 | 0.78 | 0.46–1.34 | 0.37 |
N (N0 vs. N1N2) | 1.59 | 1.15–2.19 | 0.01 | 1.73 | 0.52–5.76 | 0.38 |
M (M0 vs. M1) | 1.74 | 0.92–3.30 | 0.09 | – | – | – |
Stage (stage1/2 vs. stage3/4) | 1.64 | 1.22–2.20 | < 0.001 | 1.06 | 0.32–3.51 | 0.93 |
Clark level (I/II/III vs. IV/V) | 2.09 | 1.47–2.98 |  < 0.001 | 1.26 | 0.75–2.12 | 0.38 |
Age (< 60 vs. ≥ 60) | 1.59 | 1.20–2.09 | 0.001 | 1.77 | 1.12–2.81 | 0.02 |
Ulceration (no vs. yes) | 2.08 | 1.49–2.91 | < 0.001 | 1.67 | 1.05–2.66 | 0.03 |
New tumor event (no vs. yes) | 0.75 | 0.51–1.09 | 0.13 | – | – | – |
Cancer status (tumor free vs. with tumor) | 4.27 | 3.00–6.07 | < 0.001 | 5.82 | 3.32–10.21 |  < 0.001 |
Race (Asian vs. White) | 0.22 | 0.10–0.48 | < 0.001 | 0.55 | 0.07–4.17 | 0.56 |